START FREE TRIAL

Salesforce Just Bought Momentum — But The REAL Play Is Workflow Control!

It has been a busy stretch for Salesforce (NYSE:CRM). Fresh off a strong fiscal third quarter, the company is...

Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?

Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline add-on in a year already defined...

Is Apple Outflanking Meta With This Q.AI Move?

Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...

Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?

Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

APi Group CertaSite Acquisition Sparks Investor Debate

In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG)...

Netflix Warner Bros Acquisition Could Change Streaming Forever

The streaming wars just got their biggest twist yet. Netflix, already the world’s largest video platform by subscribers, is...

Paramount Warner Bros Merger vs. Netflix Explained!

The gloves are off in the media megamerger race. In a bold, attention-grabbing move, Paramount Skydance Corp. has hiked...

Abbott Exact Sciences Acquisition: $21B Cancer Gamble

Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...

Adobe Acquires Semrush: Game-Changer for Marketers?

Adobe just made a bold move that could shift the digital marketing landscape—again. Last week, the company announced a...

Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!

Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...

Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda

Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...